Cocer Peptides ye ŋlɔe 
ŋkeke 27 enye sia.
Lãmetsiwo kple lãkusiwo ɖɔɖɔɖo nye ŋutilã ƒe dɔwɔwɔ vevi siwo léa lãmekawo ƒe dɔwɔwɔ, xɔtuɖoɖo ƒe blibonyenye, kple dɔwɔwɔ ƒe gbugbɔgatu le abixɔxɔ megbe ɖe te, si lɔ mɔnu sesẽwo abe lãmenugbagbeviwo ƒe dzidziɖedzi, lãmenugbagbeviwo godo ƒe matriki (ECM) ƒe tɔtrɔ, ʋukawo ƒe dzɔdzɔ, kple dɔdzẽ ƒe nuto suewo ƒe ɖoɖowɔwɔ ɖe eme. Nɔnɔme vevi siwo le go sia me—siwo dometɔ aɖewoe nye lãmekawo ƒe tsitsi, abi ƒe dɔyɔyɔ, ƒunukpeƒewo ɖɔɖɔɖo, kple kamedefefe ƒe abixɔxɔ ƒe hayahaya—nɔ te ɖe nudede nyawo me pɛpɛpɛ le satellite cell ƒe dɔwɔwɔ, fibroblast ƒe dɔwɔwɔ, ƒunukpeƒetetedɔ ƒe lãmenugbagbeviwo ƒe dɔwɔwɔ, kple ahɔhɔ̃mekawo ƒe kadodowo dzadzraɖo me dzi. Peptide-nu siwo ƒe dɔwɔwɔ lolo eye woƒe taɖodzinu tɔxɛwo le wo ŋu la ate ŋu atrɔ asi le lãmenugbagbeviwo ƒe dzesimɔwo ŋu etɔxɛe, ado lãmenugbagbeviwo ƒe gbugbɔgadzɔ ɖe ŋgɔ, eye woaxe mɔ ɖe fibrosis nu, eye wova zu dɔwɔnu vevi siwo woatsɔ aɖu mɔxenuwo dzi le nuwo ɖɔɖɔɖodɔdamɔnu xoxowo me eye woaɖe mɔkpɔkpɔ si li be woazã wo le kamedefefewo ƒe atikewɔwɔ, nuveviwɔame ƒe amekoko, kple gbugbɔgawɔ ƒe atikewɔwɔ me afia.
Nɔnɔmetata 1 Ƒumelãwo ƒe lãmekawo ɖɔɖɔɖo le abixɔxɔ megbe ƒe wɔwɔfia si ɖe lãmekawo ɖɔɖɔɖo ƒe akpa etɔ̃awo fia. Dzɔtsoƒe: Lãmenugbagbeviwo Kple Lãmetsiŋusẽ Ŋuti Numekuku.
Dɔdamɔnu Veviwo
1. Lãmetsiwo ƒe Tsitsi: Edoa Myocyte ƒe Dɔwɔwɔ Do Ŋgɔ Kple Mɔxexe Ðe Catabolism Nu
Peptide-nu siwo naa lãmekawo ƒe lolome kple dɔwɔwɔ nyona ɖe edzi to anabolic kple catabolic mɔwo dzi kpɔkpɔ me.
Satellite cell ƒe dɔwɔwɔ kple woƒe dzidziɖedzi
Peptide siwo ɖea tsitsi ƒe lãmetsiwo ɖa (le kpɔɖeŋu me, CJC-1295) naa tsitsi ƒe lãmetsi ƒe secretagogue receptors wɔa dɔ, si doa ŋusẽ pituitary tsitsi ƒe lãmetsi ƒe dodo eye wòdoa insulin-like growth factor-1 (IGF-1) ƒe wɔwɔ ɖe ŋgɔ. Esia naa mɔ siwo le anyime la wɔa dɔ be woana satelait lãmenugbagbeviwo natrɔ tso nɔnɔme si me wozi ɖoɖoe me ayi nɔnɔme si me wole dzidzim ɖe edzi me, si wɔnɛ be myofibrillar protein ƒe wɔwɔme kabakaba. Peptide siawo xea mɔ na ubiquitin-proteasome system ƒe dɔwɔwɔ hã, si ɖea lãmekawo me protein ƒe gbegblẽ dzi kpɔtɔna, si wɔnɛ be wosɔ na lãmekawo ƒe vuvu le tsitsi ta, esi womegazãna o, kple lãmekawo ɖɔɖɔɖo le kamedede megbe.
Adipocyte ƒe lãmenugbagbeviwo ƒe dɔwɔwɔ kple lãmekawo takpɔkpɔ
Peptide aɖewo (le kpɔɖeŋu me, AOD 9604) ɖea inflammatory factor ƒe dodo le adipocytes kple myocytes dome dzi kpɔtɔna to brown adipose tissue thermogenesis kple white adipose browning ƒe dɔwɔwɔ me, si wɔnɛ be lãmekawo ƒe nuto suea nyona ɖe edzi. Woƒe ametakpɔkpɔ ƒe ŋusẽkpɔɖeamedzi ɖe myocyte mitochondrial ƒe dɔwɔwɔ dzi ɖea oxidative damage si kamedede hena vɛ dzi kpɔtɔna eye wòdoa ɖeɖiteameŋu ƒe hayahaya ɖe ŋgɔ.
2. Abi ƒe Dɔyɔyɔ: Afɔɖeɖe Geɖe ƒe Ðoɖowɔwɔ le Dzadzraɖo ƒe Dɔwɔna Ŋu
Tso alesi dɔdzẽ wɔa nui ɖe lãmenugbagbeviwo ƒe tɔtrɔ ŋu dzi la, peptide-nu siwo kpɔa abi ƒe dɔyɔyɔ ƒe tsatsam bliboa dzi.
Dzoxɔxɔ ƒe akpa ƒe ɖoɖowɔwɔ
Peptides abe TB 500 ene xea mɔ na neutrophil ƒe dɔwɔwɔ fũ akpa kple free radical ƒe dodo, si ɖea dɔdzẽ ƒe nugbegblẽ dzi kpɔtɔna. Wodoa macrophage ƒe vovototodedeameme ɖe ŋgɔ hã ɖe M2 ƒe nɔnɔme si tsia dzodzodzoetsitsi nu, si wɔnɛ be lãmenugbagbevi siwo ku la ɖeɖeɖa kabakaba eye wowɔa nuto sue si sɔ be woadzrae ɖo.
Peptide siwo wua dɔlékuiwo (le kpɔɖeŋu me, LL37) wua dɔlékuiwo tẽ eye woɖɔa dɔlélenutsiŋutete ƒe lãmenugbagbeviwo ƒe chemotaxis ɖo, si ɖea abi ƒe dɔlékuiwo xɔxɔ ƒe afɔkua dzi kpɔtɔna. Woƒe dɔwɔwɔ le lãkusi ƒe tsitsinu ƒe xɔlawo ŋu doa ŋusẽ keratinocyte ƒe ʋuʋu ƒe ŋutete.
Proliferation kple remodeling phase dodo ɖe ŋgɔ
Dɔgbometakpɔnu peptidewo (le kpɔɖeŋu me, BPC-157) naa ʋukawo ƒe lãmenugbagbeviwo ƒe tsitsi ƒe akpa (VEGF) kple fibroblast ƒe tsitsi ƒe akpa (FGF) ƒe dzesiwo wɔa dɔ, si doa lãmenugbagbeviwo ƒe dzidziɖedzi kple ʋuka yeyewo ƒe dɔwɔwɔ ɖe ŋgɔ be wòana abi ƒe ʋu ƒe gbugbɔgatu kabakaba. Wodoa collagen kple fibronectin ƒomevi I ƒe ɖeɖefia hã ɖe dzi, si wɔnɛ be granulation lãmenugbagbeviwo ƒe ŋusẽ nyona ɖe edzi.
Peptides abe GHK-Cu, abe akɔbli ion tsɔlawo ene, doa lysyl oxidase ƒe dɔwɔwɔ ɖe ŋgɔ, si wɔnɛ be collagen fiber ƒe cross-linking kple tsitsi kabakaba be abi ƒe lãkusi ƒe tensile ŋusẽ nanyo ɖe edzi. Woƒe mɔxexe ɖe matrix metalloproteinases nu ɖea ECM ƒe gbegblẽ fũ dzi kpɔtɔna, si xea mɔ na abi ƒe dzidziɖedzi.
Nɔnɔmetata 2 Bioactive peptides kple proteins ɖɔa ROS ƒomea ɖo le ŋutilã kple dɔléle ƒe dɔwɔwɔwo me. Dzɔtsoƒe: Bioactive peptides kple proteins na lãmenugbagbeviwo ɖɔɖɔɖo: microenvironment modulation, susu tsɔtsɔ yi na amewo, kple dɔdamɔnu ƒe ŋutete (2024).
3. Ƒunukpeƒewo Dzadzraɖo: Ƒunukpeƒewo Takpɔkpɔ Kple Ƒunukpeƒetetedɔ Ŋuti Ðoɖowɔwɔ
Esi peptide-nu siwo ƒe taɖodzinue nye be yewoakpɔ ƒunukpeƒetetedɔ ƒe vuvu kple ƒunukpeƒetetedɔ ta la, wokpɔa ƒunukpeƒeŋusẽwo ta eye woxea mɔ na fibrosis.
Ƒumeŋuɖui ƒe matriki dzi kpɔkpɔ
Peptide siwo do ƒome kple chondroitin (le kpɔɖeŋu me, Chonluten) doa proteoglycans kple collagen ƒomevi II ƒe wɔwɔme ɖe ŋgɔ, si xea mɔ na ƒunukpeƒetetedɔ ƒe gbegblẽ eye wòhea ƒunukpeƒetetedɔ ƒe gbegblẽ ɖe megbe le ƒunukpeƒetetedɔ me. Woƒe domenyiŋusẽfianu siwo do ƒome kplii ƒe dziyiyi léa chondrocyte ƒe nɔnɔme me ɖe asi, si ɖea hypertrophy kple calcification dzi kpɔtɔna.
Peptide siwo kpɔa ƒunukpeƒewo ta (le kpɔɖeŋu me, Cartalax) xea mɔ na fibroblast-like synoviocytes (FLS) ƒe dzidziɖedzi fũ akpa kple pro-inflammatory factor secretion, si ɖea ƒunukpeƒetetedɔ si ƒunukpeƒetetedɔ hena vɛ dzi kpɔtɔna, si sɔ na kpekpeɖeŋunadɔdamɔnu le ƒunukpeƒetetedɔ kple ƒunukpeƒetetedɔ si gblẽa nu le ame ŋu me.
Lãmenugbagbeviwo takpɔkpɔ kple apoptosis ƒe mɔxexe
SS-31, si nye peptide si woɖo ɖe mitochondria ŋu, gena ɖe chondrocyte mitochondrial membranes me, si léa membrane ƒe ŋutete ƒe liƒo me ɖe asi eye wòɖea oxidative stress-induced apoptosis dzi kpɔtɔna be wòakpɔ deep articular cartilage cells ƒe agbetsitsi ta.
4. Kamedefefewo me Nuveviwɔamewo Gbɔkpɔkpɔ: Dzadzraɖo Kple Dɔwɔwɔ Gbugbɔgatu Kabakaba
Le lãmekawo ƒe tete, lãkusi ƒe abixɔxɔ, kple lãkusi ƒe aɖatsi gome la, peptide-nu siwo naa hayahaya ƒe ŋutete nyona ɖe edzi to lãmenugbagbeviwo ɖɔɖɔɖo ƒe dɔwɔwɔ kple ECM gbugbɔgaɖɔɖo dzi kpɔkpɔ me.
Tendon/ligament dzadzraɖo ƒe nyonyome
Peptide aɖewo (le kpɔɖeŋu me, TB 500 ƒe kakɛ) doa lãkusi ƒe lãmenugbagbeviwo ƒe vovototodedeameme ɖe ŋgɔ va zua tenocytes, wodoa tenascin-C kple tendonectin ƒe ɖeɖefia ɖe dzi, wodoa collagen fiber ƒe ɖoɖowɔwɔ ɖe ɖoɖo nu ɖe edzi, ɖea abi ƒe lãkusiwo ƒe wɔwɔ dzi kpɔtɔna, eye wònaa teƒe siwo woxɔ abi ƒe mɔ̃ɖaŋununya ƒe nɔnɔmewo nyona ɖe edzi.
Peptides abe CJC-1295 ene, to tsitsiŋusẽ ƒe dodo ɖa atraɖii me, doa satelait lãmenugbagbeviwo ƒe ʋuʋu yi lãkusi siwo xɔ abi me ɖe ŋgɔ, si wɔnɛ be collagen fiber ƒe wɔwɔme kabakaba eye wònaa kamedefefe ƒe abixɔxɔ ƒe hayahaya ƒe ɣeyiɣia dzi ɖena kpɔtɔna—eɖea vi na kamedefefewɔlawo ƒe hayahaya kabakaba.
Nyanuwuwuw
Peptide nuawo zazã le lãmeka kple lãkusiwo dzadzraɖo me de dzesi atikewɔwɔ ƒe ŋgɔyiyi tso 'passive repair' yi 'active regeneration.' To taɖodzinu veviwo abe satellite cell activation, ECM remodeling, angiogenesis, kple inflammation regulation ene me la, nu siawo da sɔ le anabolic kple catabolic metabolism me le lãmeka ƒe tsitsi me, wowɔa ɖoɖo ɖe multistage processes ŋu le abi me dɔyɔyɔ, kpɔa ƒunukpeƒe ƒe ƒuƒoƒo ta eye wòxea mɔ na dɔdzẽ le ƒunukpeƒewo dzadzraɖo me, eye wònaa dɔwɔwɔ gbugbɔgatu kabakaba le kamedefefe ƒe abixɔxɔ me—si ɖea mɔ̃ɖaŋununya ƒe viɖe siwo le akpa vovovowo me fiana.
NYATAKAKAWO KPLE NUSIWO WOTSƆ ƑE NYATAKAKA SIWO KAtã WOÐO LE NYATAKAKADZRAÐOƑE SIA ME LA KPLE NYATAKAKAWO kaka KPLEE NUFIAFIA ƑE TAÐOÐOWO KO.
Wotrɔ asi le atike siwo wona le nyatakakadzraɖoƒe sia ŋu na numekuku le vitro ɖeɖeko. Wowɔa numekuku le vitro (Latingbe me: *le ahuhɔ̃e me*, si gɔmee nye le ahuhɔ̃e me) le amegbetɔ ƒe ŋutilã godo. Atike siawo menye atikewo o, United States ƒe Nuɖuɖu Kple Atike Ŋuti Dɔwɔƒe (FDA) meda asi ɖe wo dzi o, eye mele be woazã wo atsɔ axe mɔ ɖe atikewɔwɔ, dɔléle, alo dɔléle aɖeke nu, adae, alo adae o. Se de se vevie be woatsɔ atike siawo ade amegbetɔ alo lãwo ƒe ŋutilã me le mɔ ɖesiaɖe nu.
